Search Results - "HOLTMANN, G."

Review article: associations between Helicobacter pylori and obesity ‐ an ecological study by Lender, N., Talley, N. J., Enck, P., Haag, S., Zipfel, S., Morrison, M., Holtmann, G. J.

“…Summary Background There is emerging debate over the effect of Helicobacter pylori infection on body mass index (BMI). A recent study demonstrated that…”
Get full text

Characterisation of the gastrointestinal mucosa‐associated microbiota: a novel technique to prevent cross‐contamination during endoscopic procedures by Shanahan, E. R., Zhong, L., Talley, N. J., Morrison, M., Holtmann, G.

“…Summary Background The mucosa‐associated microbiota appears to be highly relevant to host–microbe interactions in the gastrointestinal (GI) tract. Thus,…”
Get full text

Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity by Sternes, P. R, Brett, L, Phipps, J, Ciccia, F, Kenna, T, de Guzman, E, Zimmermann, K, Morrison, M, Holtmann, G, Klingberg, E, Mauro, D, McIvor, C, Forsblad-d'Elia, H, Brown, M. A

“…Abstract Background Multiple studies have confirmed dysbiosis in ankylosing spondylitis (AS) and inflammatory bowel disease (IBD); however, due to…”
Get full text

The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting by Koloski, N. A., Jones, M., Hammer, J., von Wulffen, M., Shah, A., Hoelz, H., Kutyla, M., Burger, D., Martin, N., Gurusamy, S. R., Talley, N. J., Holtmann, G.

“…Background The clinical assessments of patients with gastrointestinal symptoms can be time-consuming, and the symptoms captured during the consultation may be…”
Get full text

A randomized placebo‐controlled trial on the effects of Menthacarin, a proprietary peppermint‐ and caraway‐oil‐preparation, on symptoms and quality of life in patients with functional dyspepsia by Rich, G., Shah, A., Koloski, N., Funk, P., Stracke, B., Köhler, S., Holtmann, G.

“…Background Functional dyspepsia (FD) is a very common condition affecting more than 10% of the population. While there is no cure, a few drugs have been found…”
Get full text

Letter: budesonide for functional dyspepsia with duodenal eosinophilia—randomised, double‐blind, placebo‐controlled parallel‐group trial by Talley, N.J., Walker, M.M., Jones, M., Keely, S., Koloski, N., Cameron, R., Fairlie, T., Burns, G., Shah, A., Hansen, T., Harris, G., Holtmann, G.

“…LINKED CONTENT This article is linked to Ronkainen et al paper. To view this article, visit https://doi.org/10.1111/apt.15308…”
Get full text

Editorial: the burden of chronic liver disease – an ecological method sees the wood for the trees. Authors’ reply by Wulffen, M., Holtmann, G.

Get full text

Treatment of irritable bowel syndrome with herbal preparations: results of a double‐blind, randomized, placebo‐controlled, multi‐centre trial by Madisch, A., Holtmann, G., Plein, K., Hotz, J.

“…Summary Background : Herbal medications have been used in many countries for the treatment of patients with irritable bowel syndrome. Controlled data…”
Get full text

Deliberate foreign body ingestion in patients with underlying mental illness: A retrospective multicentre study by Kaazan, P, Seow, W, Tan, Z, Logan, H, Philpott, H, Huynh, D, Warren, N, McIvor, C, Holtmann, G, Clark, SR, Tse, E

“…Objective Deliberate foreign body ingestion (DFBI) is characterised by recurrent presentations among patients with mental health conditions, intellectual…”
Get full text

Transdiagnostic internet-delivered cognitive-behaviour therapy (CBT) for adults with functional gastrointestinal disorders (FGID): A feasibility open trial by Dear, B.F., Fogliati, V.J., Fogliati, R., Gandy, M., McDonald, S., Talley, N., Holtmann, G., Titov, N., Jones, M.

“…Many people with functional gastrointestinal disorders (FGIDs) face significant barriers in accessing psychological treatments that are known to reduce…”
Get full text

Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease by Tye-Din, Jason A, Daveson, A James M, Goldstein, Kaela E, Hand, Holly L, Neff, Kristin M, Goel, Gautam, Williams, Leslie J, Truitt, Kenneth E, Anderson, Robert P

“…Patients with coeliac disease (CD) commonly report a variety of adverse symptoms to gluten, but descriptions of the symptomatic response in the literature may…”
Get full text

A 13‐nation population survey of upper gastrointestinal symptoms: prevalence of symptoms and socioeconomic factors by Haag, S., Andrews, J. M., Gapasin, J., Gerken, G., Keller, A., Holtmann, G. J.

“…Aliment Pharmacol Ther 2011; 33: 722–729 Summary Background  Previous data collected in separate studies using various different survey instruments have…”
Get full text

The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data by Alammar, N, Wang, L, Saberi, B, Nanavati, J, Holtmann, G, Shinohara, R T, Mullin, G E

“…Peppermint oil (PO) has intrinsic properties that may benefit patients with irritable bowel syndrome (IBS) symptoms. The study objective was to determine the…”
Get full text

The effect of functional gastrointestinal disorders on psychological comorbidity and quality of life in patients with inflammatory bowel disease by MIKOCKA‐WALUS, A. A., TURNBULL, D. A., ANDREWS, J. M., MOULDING, N. T., HOLTMANN, G. J.

“…Summary Background  Symptoms of functional gastrointestinal disorders (FGIDs) are common in patients with inflammatory bowel disease (IBD). Psychological…”
Get full text

Letter: inverse correlation between Helicobacter pylori and obesity – a conclusion too early? Authors' reply by Holtmann, G. J., Talley, N. J., Morrison, M.

Get full text

Letter: investigating the intestinal mucosa‐associated microbiota – relevance and potential pitfalls. Authors’ reply by Shanahan, E. R., Zhong, L., Talley, N. J., Morrison, M., Holtmann, G.

Get full text

A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease by Sack, C., Phan, V.A., Grafton, R., Holtmann, G., van Langenberg, D.R., Brett, K., Clark, M., Andrews, J.M.

“…Inflammatory bowel disease (IBD) is a chronic condition, yet the model of care is often reactive. We sought to examine whether a formal IBD service (IBDS)…”
Get full text

Is there an association between hospital accreditation and patient satisfaction with hospital care? A survey of 37 000 patients treated by 73 hospitals by SACK, C., SCHERAG, A., PLÜTKES, P., GÜNTHER, W., JÖCKEL, K.-H., HOLTMANN, G.

“…Objective. In many countries hospitals are undergoing accreditation as mandatory or voluntary measures. It is believed that accreditation positively influence…”
Get full text

New algorithm for the treatment of gastro‐oesophageal reflux disease by TYTGAT, G. N., MCCOLL, K., TACK, J., HOLTMANN, G., HUNT, R. H., MALFERTHEINER, P., HUNGIN, A. P. S., BATCHELOR, H. K.

“…Summary Background  Gastro‐oesophageal reflux disease (GERD) is associated with a variety of typical and atypical symptoms. Patients often present in the first…”
Get full text

Liver‐related mortality in countries of the developed world: an ecological study approach to explain the variability by Wulffen, M., Clark, P. J., Macdonald, G. A., Raj, A. S., Kendall, B. J., Powell, E. E., Jones, M. P., Holtmann, G.

“…Summary Background Liver‐related mortality varies across developed nations. Aim To assess the relative role of various risk factors in relation to…”
Get full text